Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ashu Tyagi currently holds 30,905 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ashu Tyagi has been a net buyer of YMAB stock. They have purchased $6.9M and sold $0 worth of shares.
Ashu Tyagi's most recent insider trade was on Sep 16, 2025, when they sold 25,080 shares at $0.00 per share.
Ashu Tyagi serves as Executive at Y-mAbs Therapeutics, Inc. (YMAB). They have executed 7 insider transactions totaling $6.9M over their tenure at the company.
Ashu Tyagi holds the position of Executive at Y-mAbs Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Ashu Tyagi has shown a buying trading pattern, with $6.9M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ashu Tyagi was on Sep 25, 2018, when they purchased $6.9M worth of YMAB shares. This transaction involved 430,174 shares at $16.00 per share.
Ashu Tyagi currently owns 30,905 shares of Y-mAbs Therapeutics, Inc. (YMAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ashu Tyagi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ashu Tyagi has 7 Form 4 filings on record as an insider at Y-mAbs Therapeutics, Inc..
Set alerts for Ashu Tyagi and 40,000+ other insiders.